Member Info for Valhalla14

wadnob "Long tough wait but deep down it's why we knew it was a keeper" that's got to be the funniest statement I've ever read on this BB hahahaha!!

I've said this since we delisted, total narcissist and can never admit any mistakes or wrong doing, only way to do this is a class action, Ralph will go along with whatever, they have all had their money out of this so ignore what shares they have accrued, CP has had millions out of it already as have all the other placees/warrant washers and holders, all thats happening is assets liquidated and more dates missed.....Crown funding missed because they were recruiting a couple of people, absolute ******

RNS Number : 7223N
FastForward Innovations Limited
02 February 2021


FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

2 February 2021

FastForward Innovations Ltd ("FastForward" or, "FFWD")

Investee Company Update: Leap Gaming



FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note the update from IMG Arena on the launch of a unique new betting product in partnership with EuroLeague, the company owns and administers Europe's premier professional basketball competitions. FastForward has a 43.4% interest in Fralis LLC ('Leap Gaming'), which has a strategic partnership with IMG Arena and has developed the Euroleague product in partnership with IMG Arena.



Leap Gaming is a B2B developer of high-end gaming applications whose realistic 3D immersive games are offered by leading online and retail gaming operators around the world. In 2018, it formed a strategic partnership with IMG Arena, a data system division of global sports, events, and entertainment agency IMG, which provides bookmakers with live streaming and virtual sports products. This partnership sees the two companies collaborating on sales and product development initiatives; IMG Arena also holds an equity stake in Leap Gaming.



Ed McDermott, CEO of FastForward, commented: "Leap Gaming has once again demonstrated its world-leading ability to develop totally unique and innovative products that challenge other gaming developers worldwide and take gaming experiences to new levels. Since EuroLeague Basketball agreed the joint venture partnership with IMG Arena in 2015-16, both television and live audiences have increased, with 1.3 billion viewers cumulatively watching the EuroLeague on television during the 2018/19 season. The extension of this partnership with the launch of EuroLeague Instant Legends will have a significant impact on Leap Gaming, adding another important revenue stream to its suite of products across the global gaming operators."



Full Announcement Below



IMG ARENA LAUNCHES NEW VINTAGE BETTING PRODUCT IN PARTNERSHIP WITH EUROLEAGUE BASKETBALL



Play-on-demand offering boosted with creation of EuroLeague Legends product that features 10 years' highlights footage



LONDON, UK -2nd February, 2021 - IMG ARENA, a leading sports betting service and content hub, has expanded its long-standing partnership with Euroleague Basketball with the launch of EuroLeague Legends, an innovative new product line.



EuroLeague Legends uses official vintage footage from top players over the past 10 years to create instant betting events via randomly grouped clips. The product has been created by Leap Gaming*.



Euroleague Basketball, which has been an IMG ARENA partner since 2015, is the organizer of Europe's premier professional basketball competition the Turkish Airlines EuroLeague and also runs the 7DAY

https://www.forbes.com/sites/chrisroberts/2021/01/31/under-joe-biden-cannabis-stocks-will-have-a-gamestop-moment--just-like-they-have-before/?sh=170df440564e

FastForward Innovations Ltd ("FastForward" or, "FFWD")



Placing to raise £2.1 million

Issue of Equity



FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to announce that it has placed 24,705,879 new Ordinary Shares of 1p each (the 'Placing Shares') at a price of 8.5p per Placing Share (the "Placing Price") with new and existing shareholders raising gross proceeds of approximately £2.1 million (together the 'Placing'). In addition, it has issued 2,941,177 Ordinary Shares from the Company's treasury shares to Mr Lorne Abony, a former director, at the Placing Price in settlement of accrued directors fees payable in relation to calendar year 2019 and payment of which was deferred on 15 May 2020 for a period of up to 12 months.



The Placing Price represents a discount of approximately 9.86% to the Company's most recently published Net Asset Value ('NAV') per share of 9.43p and a 1.19% premium to the closing price of the Company's ordinary shares on 28 January 2021, being the last business day prior to completion of the Placing.



As part of the Placing the Company has issued one warrant for every two Placing Shares (the "Placing Warrants") exercisable at 12.75p, a 50% premium to the Placing Price.



Shard Capital are sole brokers to the Placing.



Reasons for the Placing

FastForward has to date experienced largely positive developments in this financial year (to 31 March 2021) as the Company focuses on delivering its core objective of providing investors with exposure to disruptive growth opportunities, in particular medical cannabis, that have near-term re-rating potential and would otherwise be inaccessible. The proceeds from the Placing will be used to fund a number of opportunities in line with this investment strategy.



The Placing Warrants

Each Placing Warrant will entitle the holder to subscribe for one further ordinary share of £0.01 in the capital of the Company upon payment of 12.75 pence per share on or before that date which is 24 months from the Settlement Date. The Warrants will also be subject to an accelerator provision, such as if at any time during the 24 month duration of the Warrants the 5 day volume-weighted average price (VWAP) of FastForward ordinary shares exceeds 17p per share, the Company may give warrant holders notice to exercise their Warrants within 10 business days following the Company's notice and to pay the exercise price in full within 20 business days following the Company's notice, failing which the Warrants will automatically expire.

Aberforth Partners LLP Tr1 sold

Jimmyg56 opportunist de-ramper.............BINGO!

Down she comes

Do some research? placing was at 12p.....classic ramp? hahaha I was in this before the RTO you rookie....you certainly are a space cadet jog on

why's it tanking so hard? Its gone from 12p to 22.5p and is now consolidating at 19-20p so how is that tanking? seriously there are some space cadets on these BB's.....no patience at all....you will always get a few selling placing shares and or de-risking (it's normal) without sellers there's no buyers it's as simple as that

RNS Number : 2988M
FastForward Innovations Limited
20 January 2021


FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

20 January 2021

FastForward Innovations Ltd ("FastForward" or, "FFWD")



Investee Company Update: EMMAC Life Sciences and Yooma Corp.



FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, notes the following announcement released today concerning investee company EMMAC Life Sciences ('EMMAC') and Yooma Corp. ('Yooma'). FastForward has a 2.3% interest in the issued stock of EMMAC and a 10.65% interest in the issued stock of Yooma.



The announcement is set out below without material changes or adjustments.



EMMAC LIFE SCIENCES GROUP AND YOOMA CORP.

ENTER INTO LICENSING AGREEMENT FOR EMMAC WELLNESS BRANDS



Partnership to accelerate growth and drive new market entry, with a focus on Asia



London (UK), and Toronto (Canada), January 20, 2021 - EMMAC Life Sciences Group ("EMMAC" or the "Group"), Europe's largest independent cannabis company and Yooma Corp. ("Yooma"), one of Asia's leading CBD and wellness social commerce companies, today announce they have entered into a licensing agreement whereby Yooma will license EMMAC's wellness brands, including Blossom, MYO, Hello Joya and What the Hemp (the "EMMAC Brands"). Under the terms of the Agreement, Yooma will have exclusive rights for the distribution and sale of the EMMAC Brands in China, Japan, Taiwan and Australia as well as non-exclusive distribution rights in certain other global markets.



Blossom produces premium quality CBD skincare and wellness products, currently sold through various on-line channels in Europe and select retailers in the United Kingdom. MYO Plant Nutrition combines high-quality plant ingredients with cannabinoids and other active ingredients to produce performance-enhancing nutritional supplements in 100% compostable recyclable packaging. What The Hemp and Hello Joya are both plant-based hemp snack brands currently sold through select retail partners in France with What The Hemp also being available in certain stores in the UK.



Yooma intends to integrate the EMMAC Brands into its existing sales channels in Asia, including cross-border ecommerce in China on various Alibaba platforms.



Ron Wardle, CEO of Yooma, said: "We are really excited to license these premium brands from EMMAC. The nutraceutical products will serve as an entry point for Yooma into this new product category, and exclusive licensing of Blossom will facilitate the opening of a TMall flagship store. Furthermore, we expect that the licensing model will result in improved unit economics for Yooma."



Antonio Costanzo, CEO of EMMAC, said: "We are very pleased to be partnering with Yooma. Their expertise in CBD Lifestyle brands as well as their established footprint in Asia will bring immediate scale and expertis

RNS Number : 2079M
Shield Therapeutics PLC
19 January 2021


Shield Therapeutics plc

("Shield" or the "Group" or the "Company")



Director/PDMR shareholding



London, UK, 19 January 2021: Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency with its lead product Feraccru®/Accrufer® (ferric maltol), announces that Tim Watts, Chief Executive Officer, has acquired 100,000 Ordinary Shares in the Company on 19 January 2021 for consideration of £0.6025 per Ordinary Share. Following the transaction, Mr Watts holds 748,700 shares.



The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

To get a placing away ;o) Obvious

I expect there's a couple of placees selling so will be a little overhang.....churning well at 19p level and as stated this will move fast once they clear....I took another £30k's worth yesterday.....monster in the making this one

Try doing some research then?

Smbbb Do you honestly think that Cameron will lose this if it never lists? Just for fun let's guess if it relists? How much have you got tied up here a tenner? Clown

17:39:03 54.50 537,500 292.94k O
17:38:54 55.00 500,000 275.00k O

Call them and they will adjust it for you it was the same in my account and now I can trade it under BMF7560 which is a temp code until name change CMET

Gonna get caught short here with low free float,hence the spread ;o)

That KLK are in at 5p which after consolidation is = £1.00